Navigation Links
Bayer's Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community
Date:11/20/2013

WHIPPANY, N.J., Nov. 20, 2013 /PRNewswire/ -- Bayer HealthCare and the National Hemophilia Foundation (NHF) today announced the successful conclusion of the third annual Virtual Walk for Hemophilia, an engaging, online contest designed to raise awareness and funds for those living with bleeding disorders.

The Virtual Walk for Hemophilia (www.walkforhemophilia.com) employs a website where visitors can virtually "walk" online in support of people with hemophilia. Virtual walkers choose which NHF chapter they support, and create customized avatars to represent themselves in the virtual walk.

As part of this year's Walk, Bayer provided $30,000 in sponsorship funds to the national office of the NHF and an additional $33,500 in sponsorship funds to the five chapters with the greatest number of walkers, for a total of more than $60,000.

"Bayer's Virtual Walk is a fun, exciting way for us to engage with the community," said Karen Krzmarzick, Executive Director of the Hemophilia Association of the Capital Area. "We're grateful for the sponsorship funds Bayer provided to us, and know that they will help us do even more for our constituents in the coming year."

The chapters receiving sponsorship funds are:

First place: Hemophilia Association of the Capital Area, with 2729 walkers, received $15,000
Second place: Nevada Chapter, NHF, with 1133 walkers, received $10,000
Third place: Bleeding Disorders Alliance Illinois, with 1075 walkers, received $5,000
Fourth place: Great Lakes Hemophilia Foundation, with 385 walkers received $2,500
Fifth place: Colorado Chapter, NHF, with 351 walkers, received $1,000

Bayer introduced a new twist this year, designed to increase awareness virally, by providing an additional walker "credit" to chapters whose participants shared the event on Twitter or Facebook.   In addition, any chapter with more than 500 virtual walkers received $500, and any chapter with more than 1,000 walkers received $1,000 in sponsorship funds. 

About Hemophilia A
Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is a largely inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the, joints, muscles or internal organs.

About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for Cardiopulmonary Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

BAYER®  and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Intended for U.S. Media Only

KN28000713


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
3. Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
4. CorMedix to Report Third Quarter Financial Results on November 19, 2013
5. International Isotopes Inc. Announces Third Quarter And Nine Months 2013 Financial Results
6. ULURU Inc. Reports Third Quarter 2013 Financial Results
7. China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
8. Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
9. Vermillion Reports Third Quarter 2013 Results
10. ConvaTec Announces 2013 Third Quarter Earnings Call
11. SPO Global Reports Results for Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... MARLBOROUGH, Mass., May 10, 2017 Hologic, Inc. ... financial results for the fiscal second quarter ended April ... (EPS) of $1.84 increased 666.7% compared to the prior ... business resulted in a significant gain, while non-GAAP diluted ... increased 3.2%, or 3.8% in constant currency terms.  Excluding ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet ... in musculoskeletal healthcare, today announced it has earned a ... of 2017" list. The Company was ranked among 500 ... Large Employers and Healthcare Equipment and Services. ... based on an anonymous, independent survey of over 30,000 ...
(Date:5/8/2017)... Mich. , May 8, 2017  Diplomat Pharmacy, ... WRB Communications, Inc. ("WRB"), a health care service ... . WRB specializes in relationship management programs ... WRB will join ... Diplomat,s commercialization support services for manufacturers, biotech firms, and ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... , ... Amir Qureshi, MD is the first physician in Arkansas to implant ... The Nuvectraâ„¢ Algovita SCS System has been FDA approved as a treatment option for ... to introduce the most powerful SCS system and the only stretchable lead on the ...
(Date:5/26/2017)... Minneapolis, MN (PRWEB) , ... May 26, 2017 , ... ... five U.S. states with the healthiest seniors are located in the Midwest. With the ... 2060, more and more people are concerned with both the quality and affordability of ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on ... will continue to be available at a discounted crowdfunding price on Indiegogo . ... they are, I also wanted to bring a fidget toy to the market that ...
(Date:5/26/2017)... ... 2017 , ... Silver Birch of Hammond, a new assisted lifestyle community, has ... acres of land at 5620 Sohl Avenue in Hammond, serves older adults who need ... studio and one-bedroom apartments. Each of the private apartments at Silver Birch features a ...
Breaking Medicine News(10 mins):